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Mapping biological process relationships and disease
perturbations within a pathway network
Ruth Stoney1, David L Robertson2, Goran Nenadic1 and Jean-Marc Schwartz3
Molecular interaction networks are routinely used to map the organization of cellular function. Edges represent interactions
between genes, proteins, or metabolites. However, in living cells, molecular interactions are dynamic, necessitating context-
dependent models. Contextual information can be integrated into molecular interaction networks through the inclusion of
additional molecular data, but there are concerns about completeness and relevance of this data. We developed an approach for
representing the organization of human cellular processes using pathways as the nodes in a network. Pathways represent spatial
and temporal sets of context-dependent interactions, generating a high-level network when linked together, which incorporates
contextual information without the need for molecular interaction data. Analysis of the pathway network revealed linked
communities representing functional relationships, comparable to those found in molecular networks, including metabolism,
signaling, immunity, and the cell cycle. We mapped a range of diseases onto this network and ﬁnd that pathways associated with
diseases tend to be functionally connected, highlighting the perturbed functions that result in disease phenotypes. We
demonstrated that disease pathways cluster within the network. We then examined the distribution of cancer pathways and
showed that cancer pathways tend to localize within the signaling, DNA processes and immune modules, although some cancer-
associated nodes are found in other network regions. Altogether, we generated a high-conﬁdence functional network, which avoids
some of the shortcomings faced by conventional molecular models. Our representation provides an intuitive functional
interpretation of cellular organization, which relies only on high-quality pathway and Gene Ontology data. The network is available
at https://data.mendeley.com/datasets/3pbwkxjxg9/1.
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INTRODUCTION
Cellular processes are carried out by groups of interacting
proteins.1 Understanding how these spatially and temporally
organized sets of interactions lead to biological processes is
fundamental to our comprehension of the cell. The conventional
approach used to study function has been based on molecular
interaction networks, which have improved our understanding of
disease,2–4 infection,5 drug pharmacodynamics,6 and evolution.7
In this paper, we describe data and networks as “molecular” if they
are concerned with interactions between individual biological
molecules. This is in contrast to our focus on pathway-level
representations, which represent pathway gene sets, with inter-
actions between individual molecules subsumed into the “path-
way nodes”. Pathways are considered to collectively participate in
biological processes, the functions of individual genes or gene
products are not represented.
There are various approaches for studying biological processes
using molecular interaction networks. Protein–protein interaction
(PPI) data is frequently used to construct networks, in which
proteins are shown interacting with functionally related partners.
This results in the emergence of functionally related sub-networks
known as “functional modules”.3 Modular organization of function
has been shown to exist across species, and is used to predict
gene function.8,9 Similar networks have also been generated using
co-expression data,7 genetic interaction data,10 and by combining
data types.11 However, a disadvantage is that these networks
contain false positive and false negative interactions, which may
distort our understanding of functional organization.12–14
In PPI networks, the edges link each protein to all of its known
interacting partners. However, protein interactions are often
dynamic, assembling when needed to perform a function, then
disassembling.15–17 This property is not captured in static
networks, where interactions appear permanent in time. Proteins
may participate in different functions, depending on the interac-
tions they make in various cellular contexts18,19 and subcellular
compartments,20 making representation of dynamic interactions
critical for the accurate portrayal function.21,22 To capture the
inherently temporal nature of molecular interactions, dynamic
models incorporating additional data have been developed. For
example, gene expression data have been mapped onto PPI
networks to reﬂect the dynamic nature of protein interactions.
Active sub-networks, deﬁned as connected regions of the network
that show altered gene expression under particular conditions,
can then be identiﬁed.23–25 Additionally, longitudinally sampled
data can be represented using multiple time series networks.15 An
advantage of this approach is that reﬁning the edges to those
present at each time point produces modules that are smaller and
more functionally speciﬁc.17 However, the use of gene expression
data fails to capture interactions between proteins that do not
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have correlated expression.12 The correlation between gene
expression and protein abundance is also weak.26–30
We suggest that the utilization of more reliable data could allow
functional models to reach their full potential. In this work, we
address the previous limitations by introducing a representation
of cellular functions that uses pathways, rather than genes, as the
constitutive elements. Pathways are comprised of sets of proteins
(and complexes) that interact with each other serially, for example,
to form signaling or metabolic pathways. This allows us to group
sets of proteins known to interact under particular conditions.
Although pathway data is based on molecular interactions within
a speciﬁc cellular functional context, individual pathways do not
include all the interactions that each protein participates in.
Pathway data is considered to be more reliable than molecular
data since it is based on a consensus reached by biochemists over
an extended period of time and repeated experimentation. In this
study we have excluded the individual molecular interactions and
represented pathways as sets of proteins. As a consequence of this
reduction in network complexity, the issues of individual false
positive and negative PPIs are avoided, since individual molecular
interactions are not represented in the network. The method also
avoids gene expression data and the assumption that gene
expression represents protein levels. In addition, the pathway
model allows proteins to be represented independently in
multiple pathways, separating pleiotropic functions. Finally, by
simplifying the complexity of PPI networks to a smaller number of
pathways, computational analysis becomes less demanding and
more accessible.
We present a human pathway network representing global
biological function. By incorporating pathways from multiple data
sources we aim to maximize functional coverage while minimizing
the overlap between pathways. To assess the ability of our
network to interpret disease functions, we mapped a broad range
of disorders onto the network, before focusing more speciﬁcally
on cancer. Disease pathway “modules” or clusters are known to
form within molecular networks, showing overlap with functional
modules.2,3,31 Cancer genes have been found to be especially
highly connected within PPI networks,2 with different types of
cancer forming highly connected overlapping modules.32 Our
representation provides a higher-level view of the pathways and
functions affected by disease, without the inaccuracies inherent in
molecular-level interaction data.
RESULTS
Global functional organization can be represented by a non-
redundant set of 1014 pathways
In order to generate a representation of biological processes
based on pathways, we ﬁrst selected a set of non-redundant,
functionally annotated human pathways (Fig. 1a). The original
dataset contained 4,011 pathways and 11,196 genes. Figure 1b
shows the proportion of pathways that were removed at each
stage of pathway preparation.
Diseases reﬂect perturbations of normal cellular functions. In
order to represent diseases we ﬁrst generated a network of
pathways showing the cell in a normal, healthy state, then
mapped disease genes onto the network. However, the data set
contained pathways that were already representations of disease
perturbations, and were therefore unsuitable for inclusion in the
Fig. 1 Diagrammatic representation of a the project work ﬂow and b the proportion of pathways that were removed from the initial data set
because they had identical gene sets, were disease pathways, could not be functionally annotated, or were redundant (not in the set cover)
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network. Speciﬁcally, disease pathways such as colorectal cancer,
asthma and HIV infection were removed from the data set. Drug
metabolism and addiction pathways also show the cell in an
altered state, therefore drug metabolic pathways such as
doxorubicin and statin pathways, and addiction pathways such
as cocaine addiction were removed. A total of 484 pathways, with
225 pathways containing disease terms, 30 containing drug terms
and 221 addiction terms were removed (see Methods). This only
reduced the number of genes in the data set to 10,833.
The Gene Ontology33 (GO) assigned a mean of 8.2 terms to each
gene (median 5, standard deviation 9.2). Addition of parent terms
increased the mean number of GO terms per gene to 75.3 (median
52, standard deviation 71.3). It was necessary to remove 1263
genes, as they did not have experimentally validated GO
annotations, resulting in a loss of two pathways. Of the
unannotated genes, 4.0% had no Biological Process annotations
and 7.6% only had Biological Process annotations inferred from
electronic annotation (IEA), which are considered less reliable. We
removed 298 pathways with fewer than four annotated genes, as
they were too small for enrichment analysis. Enrichment analysis
returned at least one high conﬁdence enriched Biological Process
GO term (p-value < 0.01) for 2514 out of the 2521 remaining
pathways. Pathways without enriched GO terms were removed, as
functional annotations were required to create edges in the
network.
Between 1 and 3459 enriched GO terms were assigned to each
pathway (mean 411.8, standard deviation 441.0), using the p-value
threshold of 0.01. These enriched GO terms varied greatly in their
signiﬁcance and included many similar terms and parent terms.
We aimed to generate a network that linked pathways based on
the similarity of their enriched GO terms; however, GO terms
assigned with low signiﬁcance had the potential to make spurious
connections or link pathways based on highly general terms. To
address these issues we selected the most speciﬁc set of GO terms
available to represent the genes in the pathway. We used the set
cover for enrichment analysis algorithm (see “Minimisation of
pathway functional proﬁles” Section) to select the most signiﬁcant
GO terms capable of covering the genes in each pathway [Stoney
2017 submitted], reducing the mean number of GO terms from
411.8 to 4.7 (standard deviation 4.2). These reduced functional
proﬁles provide a precise representation of the pathways’ function
without large numbers of similar GO terms or parent terms.
Next we selected a subset of pathways with reduced
redundancy and minimal pathway size variability. Pathway size
was controlled since the dataset included pathways with up to
2154 genes, which are unhelpful since they lack functional
speciﬁcity. We used the proportional set cover algorithm (see
“Reduction of redundancy between pathways” Section) to reduce
redundancy while preferentially selecting pathways with sizes
close to the median size of 23.34 We allowed the set cover
algorithm to ﬁnish after 99.95% of the genes had been covered,
reducing the number of pathways required to 1014. The only
difference between this set cover and the set cover produced to
cover 100% of genes was the absence of pathways “gene
expression” and “metabolism”. This reduced the maximum path-
way size from 1442 (metabolism) to 426 (“generic transcription
pathways”), while resulting in the loss of only 4 genes.
Figure 2 shows the ability of the set cover algorithm to reduce
redundancy, by displaying the presence of genes in multiple
pathways. Prior to redundancy reduction, genes appeared in a
mean of 46.0 pathways, with many genes appearing in large
numbers of pathways. After set cover, genes appeared in a mean
of 4.2 pathways. Genuine cases of pleiotropy are preserved in the
remaining overlap, as pathways with minor overlap are not
removed. The use of this modiﬁed set cover algorithm enables us
to use the combined data sources collated by Consensus-
PathwayDB (CPDB)35 without being undermined by excessive
pathway overlap.
The Wang best-match average is the most suitable metric to
measure functional similarity of pathways
Pathways were linked to form a network based on the similarity of
their shared GO terms. We compared the Wang and Resnik
methods for measuring distances between GO term pairs (see
“Measuring semantic distances between individual GO terms“
Section). The Resnik method measures the distance between two
GO terms based on the lowest node shared by both terms within
the Gene Ontology topology (referred to as the lowest common
ancestor).36 The number of genes annotated with the lowest
common ancestor term is used to calculate the probability that
the GO terms were linked to the lowest common ancestor by
chance. In contrast, the Wang method considers all the parent
terms of both GO terms, and semantic similarity is calculated
based on the proportion of parent terms that are shared by both
terms.37 The inﬂuence of each parent term on the GO terms of
interest is considered with greater weights attributed to close
parent terms, and with “is-a” links being weighted more heavily
than “part-of” links. We then compared the pairwise and best-
match average methods for measuring distances between sets of
GO terms (see “Measuring the semantic distance between GO
sets” Section). To assess the suitability of each method, we
identiﬁed the approach that gave the greatest difference between
the semantic similarities of GO term pairs within pathways,
compared to semantic similarities between different pathways
(additional information regarding these approaches is given in the
“Methods” section). Semantically similar GO pairs are more
frequent within pathways than between them, although the
difference is small especially when using the Resnik method (Fig.
3a, b).
To generate the pairwise average measure, we calculated the
mean similarity between GO terms within each pathway and
between each pair of pathways. This increases the distinction
between semantic similarities observed between pathway nodes
and within pathways. The difference is clearer when distances
between GO terms are generated using the Wang measure (Fig.
3d), rather than the Resnik measure (Fig. 3c).
Figure 3e, f show the best-match average similarities between
and within pathways. This enhances the distinction between
semantic similarities within and between pathways, particularly
when the Wang method is used to measure distances between
GO terms.
The best-match average typically out-performs the pairwise
method when unrelated annotations are allocated to the same
Fig. 2 Genes in multiple pathways before and after applying the set
cover algorithm. Histogram showing the proportion of the genes in
the data set that appear in multiple pathways (indicating
redundancy), before and after set cover
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pathway or gene.38 This is because rather than comparing each
GO term to all available terms within each pathway or pathway
pair, the best-match average is generated using the most similar
GO term pairs. For example if “GO:1” and “GO:2” have a semantic
similarity of 0, and are both allocated to “pathway x” and “pathway
y”, the pairwise average method will assign an average similarity
of 0.5, despite the pathways having identical terms. The best-
match average would assign a more intuitive score of 1. The
ﬁnding that the Wang method outperforms Resnik indicates that
pathways are not being assigned a single semantic function but
instead are enriched with multiple semantically different GO
terms. Clusters of pathways are formed within the network when
pathways share at least one function.
The Wang method demonstrably out-performs the Resnik
measure, in each recorded instance. To interpret these results,
we note that the Resnik measure is based on the lowest common
ancestor in the GO ontology capable of covering both GO terms.
The score is calculated to describe the speciﬁcity of the lowest
Fig. 3 Pathway redundancy across set cover algorithms. Semantic similarities between GO terms in the same pathway (red) and between
pathways (blue). The y-axes show the proportion of GO term pairs allocated different semantic distances. a, b are individual semantic
similarity measures taken using the Resnik36 and Wang37 measures. c, d are pairwise average distances using the Resnik and Wang measures.
e, f are best-match average distances using the Resnik and Wang measurements
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common ancestor, based on the number of genes associated with
the term. A disadvantage of this approach is that it does not
consider how far removed each GO term is from the common
ancestor.37 Therefore two identical generic terms would receive
the same score as two highly speciﬁc child terms of the generic
ancestor, despite their increased difference. The Wang measure
considers all ancestral terms shared by two GO terms and reduces
the score if the shared ancestors are distantly removed from the
terms being compared.37 In this way it is better able to distinguish
between pairs of general GO terms and pairs of distantly removed
GO terms. For these reasons we generated the network using the
Wang method in conjunction with the best match average
method.
Pathways linked by shared functionality form a cohesive network
We linked the pathways into a network based on shared
functionality, represented by semantic similarity between GO
terms. We used the Wang method to calculate functional semantic
similarities between each pair of pathways, in order to generate a
set of weighted network edges. Inclusion of all the edges
generates a highly dense network reﬂecting the cross-talk
between all biological processes, which impedes analysis and
structural visualization of the network.
To reduce the number of edges while preserving the underlying
structure of the network, we removed weaker edges. To avoid
disconnecting large numbers of pathway nodes from the network,
we calculated the minimum edge weight threshold for reducing
edges while retaining nodes. Using the best-match average
technique the optimum threshold to provide the highest number
of nodes with the lowest number of edges was 0.56, which
conserved 987 nodes (97.1%) and 20,642 edges (4.0%). We used
the minimum edge threshold to select a set of edges to construct
the network. The resulting network was highly modular with a
clustering coefﬁcient of 0.593. Random networks generated to
preserve the degree distribution had clustering coefﬁcients
ranging from 0.186 to 0.205 (mean 2.01), indicating that the
pathway network is more modular than expected from chance.
For the 987 nodes in the network, 974 were located within the
largest connected component. Application of the Kolmogorov-
Smirnov test revealed that, in contrast to many molecular
networks,39–41 the degree distribution of the pathway network
did not follow a power law distribution (p < 0.05).
Figure 4 shows the network with a sample of GO terms
highlighted to illustrate some of the functions represented. Within
the network two major functional pathway modules relating to
metabolism and signaling can be observed. A DNA metabolic
process module links transcription processes, chromatin organiza-
tion and mitotic cell cycle to metabolism. Immune responses are
tightly clustered besides signaling and cellular responses to
stimuli. Axon guidance has nodes in the immunity network region,
reﬂecting it's role in the primary immune response.42
The functional network enables identiﬁcation of disease pathway
modules
We used enrichment analysis to assign 404 OMIM diseases to 219
pathways, using a p-value threshold of 0.01. By focusing on
diseases (e.g., cystic ﬁbrosis) rather than phenotypes (e.g., chronic
lung disease, elevated sweat chloride, and hepatomegaly) we
capture the range of symptoms induced by disorders.
To test the hypothesis that disease nodes form highly linked
disease pathway modules we measured the shortest paths
between disease nodes. Figure 5a shows the distances between
Fig. 4 Major functional clusters in the human pathway network. Weighted network of pathways, linked by shared functionality. Edges were
generated using the Wang37 best match average method to link pathways biased on their functional proﬁles, using a minimum weight cut off
of 0.56
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nodes with shared diseases, compared to an equal number of
random pathways. Shortest paths between randomized nodes
formed a roughly normal distribution, whereas shortest paths
between disease nodes tended to be shorter, indicating that
disease nodes are close within the network. To conﬁrm the
signiﬁcance of the distributions we performed a one sample
Kolmogorov–Smirnov test, which returned a p-value of <0.01.
Disease pathway modules
We identiﬁed 166 pathways enriched with cancer genes at a p-
value of <0.01. These were comprised of 39 types of cancer
affecting a range of cell types. Many pathways were enriched for
multiple cancer phenotypes (mean 3.3). The pathway associated
with the most cancer types (17) was “extracellular vesicle
mediated signaling in recipient cells”, which contains cancer
causing genes including WNT, EGFR, RAF, NRAS, and KRAS, and is
upstream of pivotal cancer pathways.43 Other pathways asso-
ciated with high numbers of cancers were the “RAC1 PAC1 P38
MMP2 pathway” containing MAPK, ERK, KRAS, RAC, RAS genes and
“copper homeostatis” which has been found to be relevant to
multiple tumor types and is being trialed as a chemotherapy
target.44
To assess the claim that cancers cluster within particular
network regions, we measured the shortest paths between cancer
nodes within the network (Fig. 5b). The Kolmogorov–Smirnov test
was applied to conﬁrm the signiﬁcance of the observed cancer
clusters (p-value < 0.01). To assess whether the formation of
disease clusters was unique to cancer we also tested pathway sets
Fig. 5 Disease module connectivity. a Shortest paths between nodes enriched for the same disease and randomized disease nodes. b
Shortest paths between nodes enriched for the same type of cancer and randomized cancer nodes. Graphs c–f show the distribution of
shortest paths and randomized shortest paths for diabetes and obesity, heart disease, immune disorders, and disorders of the nervous system
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related to diabetes and obesity, disorders of the nervous system,
immune system and cardiovascular system (Fig. 5c–f). In each
instance, pathways associated with a shared disease phenotype
were closer within the network than expected at average
(Kolmogorov–Smirnov test p-value < 0.01).
We examined the distribution of cancer within the network.
Figure 6a shows the topological position of a sample of cancers
affecting high numbers of pathways in the dataset. Cancer
pathways can be seen clustering primarily within the signaling,
immune response and DNA process network regions. The
Fig. 6 Distribution of cancer pathways. a Functional pathway network showing the distribution of pathways associated with common cancer
types (in the data set). b Distribution of colon cancer, duodenal adenocarcinoma, gastrointestinal stroma tumor, and stomach cancer
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signaling and immune network region is the most densely
populated with cancer nodes, including sarcoma pathways,
juvenile leukemia, and neuroﬁbrosarcoma. Cancer nodes also
cluster in the region concerned with DNA metabolism, response to
stimulus, and transcriptional control. Several breast cancer and
nephroblastoma pathways are also prevalent in this region.
The distribution of disease pathways within the network can
indicate similarities and common risk factors between related
distorders. To demonstrate this application, we present the
distribution of gastorintestinal cancer pathways onto the network
(Fig. 6b). Some pathway overlap between gastrointestinal stroma
tumor, colon cancer and duodenal adenocarcinoma is observed,
with shared pathways corresponding to common cancer pro-
cesses and risk factors. The common risk factors of duodenal
adenocarcinoma and colon cancer are gastrointestinal polyps and
chromic inﬂammatory bowel disease.45,46 Correspondingly, within
the network both cancers are found to be enriched in BMP
signaling pathways, which have been shown to affect gastric
inﬂammation.47 DNA repair, cell cycle, extracellular vascular
mediated signaling and RAF activation pathways were frequently
shared by multiple cancer types.
DISCUSSION
The use of molecular networks to study biological processes has
been highly insightful. However, limitations with molecular
interaction data and issues representing multi-functional genes
make the development of alternative methods a necessity. We
have constructed a functional network from existing pathway data
and biological process annotations. The pathway network portrays
a higher-level representation of the organization of biological
processes, composed of functional pathway modules. Clustering
methods used in molecular networks identify speciﬁc relationships
in which each node shows a high density of interactions with all of
the other nodes in the cluster. These methods are less suitable for
identifying linear functional structures, in which chains of nodes
interact without having a high clustering coefﬁcient. Other studies
have also approached the issue that network structures, other
than clusters, may represent functional modules.48 Pathways are
sets of interactions, which were manually curated to adopt the
most appropriate shape for the data, therefore they represent
coherent functions independently of the molecular topology.
Mapping diseases onto molecular interaction networks has
contributed towards the elucidation of disease mechanisms,4
identiﬁcation of new disease-associated genes3 and indication of
potential drug targets.49 However, gene mutations can be
phenotypically diverse, such as AKT1, which is associated with
schizophrenia, colorectal cancer, ovarian cancer and breast
cancer.50 Further evidence suggesting that diseases may act
independently within different pathways comes from the ﬁnding
that many disease pairs with shared genes do not show signiﬁcant
co-morbidity.51 Phenotypically diverse genes may also interact
with different partners in different tissues, for example AKT1
participates in a range of interactions dependent on tissue type,50
further supporting the hypothesis that the results arise from the
gene acting in different pathways. This shows that pleiotropy
allows genes to be involved in multiple disorders in different
contexts, demonstrating that pathways are better suited than
molecular networks to map functional perturbations occurring in
diseases. It should be noted that although string matching
effectively removes a majority of disease pathways from the
network, some disease pathways may remain within the network,
making identiﬁcation of the normal functions affected more
difﬁcult. In addition, removal of pathways containing disease, drug
and addiction terms may have resulted in the loss of some
pathways representing normal, healthy biological processes.
However, the remaining pathways cover 97% of the initial gene
set, reducing the impact of this concern.
Examining the similarities and differences between diseases is
necessary to assess the shared applicability of knowledge and
drugs. Our map makes these relationships immediately obvious.
This method can be generalized to facilitate understanding of any
group of disorders or phenotypes.
METHODS
To generate the data for the network, we selected a low-redundancy set of
human pathways, representing healthy biological processes. We assigned
function to the pathway nodes and generated edges building on a method
previously developed in yeast.22,34 Finally we looked at the biological
processes attributed to each area of the network and investigated the
distribution of disease pathway nodes.
Generation of pathway nodes
Pathways were downloaded from CPDB on 24th Sept 2015,35 providing a
dataset of 4011 unique pathways containing 11,196 genes. CPDB collects
and compiles data from major pathway databases such as KEGG, Reactome
and WikiPathways. Of these pathways, 706 were exact duplicates and were
removed. To be included in the network, pathways had to meet the
following three requirements, they: represent the cell in a normal, healthy
state (pathways depicting to disease perturbations, addiction and drug
metabolism were removed, see “Removing disease pathway nodes”
Section); had high conﬁdence enriched GO annotations (see “Functional
annotation of pathway nodes” Section); and belong to a reduced
redundancy subset (see “Reduction of redundancy between pathways”
Section).
Removing disease pathway nodes. To generate the functional network, we
identiﬁed a set of pathways representing normal functions. We removed
diseases by searching for disease terms within the pathway names (listed
in Supplementary Data 1), as they do not show the cell in a normal, non-
diseased state. This was considered necessary since in the later stages of
the study, we mapped diseases onto the pathway network, to reveal
functions affected by particular diseases. The inclusion of disease pathway
nodes would distort this distribution, as well as contributing to pathway
redundancy.
Functional annotation of pathway nodes. To generate the network, we
required functional proﬁles for each pathway node. We assigned high
conﬁdence GO terms to each gene, before using enrichment analysis to
annotate pathways. Any pathway node that could not be functionally
annotated was removed, as we could not calculate their similarity to other
pathway nodes to establish network edges.
Functional annotation of pathway genes: The Gene Ontology provides
Biological Process annotations for individual genes, along with information
specifying how annotations are generated.33 We assigned high conﬁdence
Biological Process GO annotations to genes (downloaded 24th Sept 2016),
discarding electronically annotated (IEA) terms as they are of lower
conﬁdence than experimentally validated terms.38
We were able to assign high conﬁdence, curated GO annotations to 88%
of the genes in normal cellular pathways. We also added all non-IEA parent
terms to the GO terms allocated to each gene, since for every GO term
associated with a gene, all of the GO term’s ancestors apply.52 To meet the
minimum criteria for enrichment analysis, each pathway must contain at
least four genes with Biological Process GO annotations.53 Any pathways
that contained fewer than four annotated genes were removed.
Functional enrichment of pathway nodes: Functional enrichment
analysis was carried out using the R package clusterProﬁler.54 Enrichment
analysis returned large sets of GO terms with p-values below 0.01 for
pathway nodes (mean of 412.0 GO terms per pathway), using the
Benjamini and Hochberg correction55 for multiple testing.
Minimization of pathway functional proﬁles. We generated minimal sets of
enriched high conﬁdence GO terms to represent all of the genes in each
pathway node, by removing similar enriched GO terms. We have
previously described a set cover algorithm that reduced redundancy from
enrichment analysis data,34 which we use here to remove redundancy
from each pathway’s enriched GO terms. The most speciﬁc/enriched GO
terms that describe the function of all the genes in each pathway are
identiﬁed and retained. GO terms describing the same genes with a lower
level of signiﬁcance are discarded, resulting in a reduced functional proﬁle
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(Supplementary Figure 1A). Note that only the non-IEA GO terms
associated with each pathway’s genes will be selected for inclusion in
the minimal proﬁle.
Reduction of redundancy between pathways. Following the removal of
disease and functionally unannotated pathway nodes, all remaining
pathway nodes were suitable for use in the network. However, because
the data source used was highly inclusive, incorporating pathways from all
areas of study, high levels of pathway overlap were present. An extensive
effort was made to remove as much data duplication as possible, while
preferentially selecting moderately sized pathways. Removal of redun-
dancy was necessary since we aimed to generate a network in which
linked nodes represent functional cooperation between distinct pathways.
We have previously described methods using set cover theory to reduce
redundancy in pathway data sets.34 These combinatorial optimization
algorithms identify subsets of pathways that cover all the genes in the
dataset. As the data set contained pathways with up to 2,154 genes,
controlling the pathway size was critical for preserving functional
speciﬁcity. We therefore selected the proportional set cover algorithm34
as it controls pathway size variability while minimizing pathway overlap.
This algorithm iteratively selects the sets containing the highest number of
uncovered elements. If multiple sets contain equal numbers of uncovered
elements, the set whose size is closest to a predeﬁned target number (such
as the average pathway size) is selected. This continues until all of the
elements in the dataset are covered (Supplementary Figure 1A).
We note that signiﬁcant improvements in the algorithm’s ability to
control pathway size variability have been observed when the algorithm
was allowed to cover “most” rather than all of the genes in the dataset.34
We found that allowing the set cover method to cover 99.95% rather than
100% of the genes in the dataset reduced the maximum pathway size from
2,154 to 426. Large reductions in pathway redundancy were also observed
(see “Results” Section).
Generation of edges
To generate the edges in the network, we measured the semantic
similarity of each pair of pathway nodes based on their associated GO
terms in the minimized functional annotation proﬁle (see “Minimisation of
pathway functional proﬁles” Section). These values, between zero and one,
formed the basis of the network edges.
Semantic similarities between pathways. To calculate the semantic
similarity between pairs of pathways, we ﬁrst needed to measure the
similarity between pairs of GO terms. This was necessary since the
methods used to generate semantic similarity are not suitable for highly
redundant sets of GO terms (see “Measuring the semantic distance
between GO sets” Section). Since pathways are enriched with multiple GO
terms, we established the most suitable method for comparing GO sets.
Various measures are available for measuring the distance between GO
terms and GO term sets.36,37,56 We selected our method based on its ability
to comply with the assumption that GO terms within pathways should be
more closely related than GO terms between different pathways.
Measuring semantic distances between individual GO terms: Of the
various methods available to measure the distance between two GO terms,
the Resnik36 and Wang37 measures have been shown to outperform other
methods in previous studies.38 We therefore implemented these methods
using the R package GOSemSim.57 Supplementary Figure 1B provides an
overview of these methods.
Measuring the semantic distance between GO sets: To calculate the
similarity between pathways, we tested two approaches: the pairwise
average method and the best-match average.38 The pairwise average
method measures the similarity between every pair of GO terms between
two pathways and then calculates the mean. The best-match average
records the similarity between each GO term in the ﬁrst pathway and the
closest GO term in the second pathway. It then performs the symmetric
calculation, before generating a mean distance based on both sets of
scores. This produced a semantic distance between every pair of pathways
generating a complete network. The complete network was impractical for
global analysis, therefore edges were reduced (see “Pruning edges
between pathway nodes” Section).
Pruning edges between pathway nodes. Our network links pathway nodes
using weighted edges based on their similarity. We aimed to reduce the
number of edges in the network to show only the most signiﬁcant
functional links between the pathways. We generated a range of 50
thresholds between zero and one and calculated the proportion of nodes
and edges retained by each. By subtracting the proportion of nodes
retained by each threshold by the proportion of edges retained, we
identiﬁed the threshold that linked the maximum number of nodes into
the network using the fewest edges. Following network generation the
degree distribution of the network was subjected to power law analysis
using the R igraph package version 1.0.0.58 The clustering coefﬁcient was
calculated using Cytoscape 3.2.159 and for comparison ten randomized
networks were generated using Network Randomizer 1.1.3.60
Mapping the distribution of biological function and disease onto
the network
Mapping global diseases onto the network. We mapped diseases on to our
network using the Human Phenotype Ontology (HPO) disease data,
downloaded on the 30th of April 2016. This dataset contained 293,556
disease gene annotations for hereditary and non-hereditary disorders; this
data includes both OMIM diseases such as “migraine, familial hemiplegic, 1;
FHM1” and phenotypes, such as “visual hallucinations”. Using the Fisher’s
exact test to map disease terms onto pathway genes we revealed 1061
disease annotations associated with at least 4 genes to ensure signiﬁcant
enrichment analysis across multiple pathways. We used the Fisher’s exact
test to identify 219 pathways associated with 404 OMIM diseases, using a
p-value threshold of 0.01.
Finding the shortest paths in disease sub-networks. To test whether
diseases tended to cluster within the network, we measured the shortest
paths between pathways associated with each disease using NetworkX.61
This algorithm calculates the shortest path between two nodes. This
measure conventionally uses distance rather than similarity. We compared
these results to sets of shortest paths generated from sets of random
nodes. We selected randomized sets of nodes of equal size to the set of
disease nodes. We repeated this method 100 times for each disease.
Mapping disease systems onto the network. We selected cancers by
searching for the terms: cancer, tumor, tumour, melanoma, carcinoma,
leukemia, lymphoma, and sarcoma in the set of HPO phenotypes enriched
to a p-value of 0.01. We mapped the locations of 166 cancer related
pathways onto the network and examined associations with biological
processes. To measure the tendency of cancers to cluster within the
network, we measured the shortest paths between pathway nodes with
the same phenotype (see “Finding the shortest paths in disease sub-
networks” Section).
Similar pathway sets were generated for the immune diseases,
cardiovascular diseases, disorders of the nervous system, obesity and
diabetes, using string searches for common disorders and anatomical
terms. Supplementary data 2 contains the full set of search terms and
generated disease pathways for each biological system.
Code availability. The code required to generate these results is available
at https://data.mendeley.com/datasets/hn6t9hjfry (see declarations for full
break down of main results and data ﬁles).
Availability of data and materials
Data ﬁles can be found at https://data.mendeley.com/datasets/37pkdchpf9/
1. The code and data ﬁles results are available at (https://data.mendeley.
com/datasets/hn6t9hjfry, https://data.mendeley.com/datasets/mnjw6rcmcc/
1). The ﬁle “main results” contains all the main results including the set cover
pathways, pathway functions, pathway disease annotations, all semantic
distances and the Cytoscape ﬁle containing the network (https://data.
mendeley.com/datasets/3pbwkxjxg9/2).
Files containing the code are available along with the CPDB and Gene
Ontology ﬁles used. OMIM ﬁles were not included for licencing reasons.
The main project is written in Python however it requires output from an
(included) R script.
Supplementary information accompanies the paper on the npj Systems Biology and
Applications website (https://doi.org/10.1038/s41540-018-0055-2).
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